Over the Counter (OTC) Analgesics Market
Over the Counter (OTC) Analgesics Market Report By Form (Tablets, Capsules, Liquid), By Drug Type (Acetaminophen, Salicylates, Nonsteroidal Anti-inflammatory Drugs), By Channel (Pharmacies, Drug Stores, Online, Modern Trade) - Regional Forecast to 2021 to 2031
Analysis of Over the Counter (OTC) Analgesics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Over the Counter (OTC) Analgesics Market Outlook
The global OTC analgesics market was valued at around US$ 25 Bn in 2020, and is expected to accelerate at a CAGR of 5% through 2031.
| Report Attributes | Details |
|---|---|
| Market Size Value in 2020 | US$ 25 Bn |
| Market Forecast Value for 2031 | US$ 40 Bn |
| Global Growth Rate (2021 to 2031) | 5% CAGR |
| Share of Top 5 Companies | 40% |
Demand for nonsteroidal anti-inflammatory drugs (NSAIDs) is set to increase at a CAGR of 4% across the assessment period of 2021 to 2031. Overall, the worldwide Over the Counter analgesics market is projected to expand 1.6X and top a valuation of US$ 40 Bn by 2031.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of OTC Analgesics from 2016 to 2020 Vs Market Outlook for 2021 to 2031
As per Fact.MR, a market research and competitive intelligence provider, the global market for OTC analgesics was valued at US$ 25 Bn in 2020.
Analgesics are anti-pain medicines that temporarily relieve or eliminate pain. With the wide availability of drugs for relieving various types of pain in distribution stores, OTC analgesics are usually purchased in large quantities.
Use of off-label drugs, which are unapproved and inexpensive medications that are effective in the treatment of diseases, has become increasingly popular in recent years.
The global OTC analgesics market has a lot of room for growth, with sales and demand for effective OTC analgesics like pain killers and pain relievers increasing significantly among people.
Introduction of healthcare reforms, as well as favorable regulatory norms around the world, have prompted the creation and implementation of several pain management programs, to lower overall healthcare costs.
All of these factors are expected to drive the market at a 5% CAGR across 2021 to 2031.
How is Rising Trend of Self-medication Fueling Market Growth of OTC Analgesics?
Constant growth of the ageing population causes various old age problems, for which, patients prefer to receive medications and treatment at home rather than going to the hospital. Individuals frequently use OTC analgesics without a prescription for pain that recurs or is of lesser severity.
According to the Centers for Disease Control and Prevention, 20.4% adults had chronic pain in 2019, and 7.4% adults had chronic pain that limited their life or work activities on a regular basis.
Demand for internal OTC analgesics and external OTC analgesics is growing as the population ages, as older people are more prone to chronic pain.
OTC analgesics help consumers meet their growing desire for self-care. Because of these numerous advantages and growing adoption of basic analgesics OTC products, self-medication is expected to continue to drive the growth of the global OTC analgesics market from 2021 to 2031.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Challenges Being Faced by OTC Analgesic Suppliers?
Wrong medication as a result of incorrect self-diagnosis can have serious consequences and is a huge obstacle to the growth of the market for OTC analgesics.
Constipation, tiredness, dizziness, and cardiac arrest are all common side-effects of OTC analgesics. In rare cases, OTC analgesics can cause serious brain damage. Addiction can result from long-term use of painkillers or analgesics.
Uncertainty regarding the introduction of more stringent regulations is expected to restrain the growth of the market over the next ten years.
Which Regional Market is the Most Profitable for OTC Analgesic Manufacturers?
North America is anticipated to hold the largest share and will remain a prominent region of the OTC analgesics market. Revenue in the North American region will grow 1.3X by 2031.
According to the Consumer Healthcare Products Association, 2019, nearly 97 % of Americans prefer to treat minor illnesses with over-the-counter medicines before getting medical help.
Demand for OTC acetaminophen and OTC salicylates has increased due to the growing geriatric population suffering from incurable health issues such as joint pain. Different types of analgesics are used in these therapies, catalyzing market growth in the region.
Furthermore, the prevalence of osteoarthritis, cardiovascular disease, and cancer has significantly increased in the region, increasing sales of OTC analgesics.
Increasing demand for OTC acetaminophen in Canada, rising sales of OTC nonsteroidal anti-inflammatory drugs (NSAIDs) in the U.K, growing opportunities for OTC analgesics manufacturers in Germany, and rise in adoption of OTC salicylates in France are contributing to global market growth prospects for OTC analgesics.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-wise Analysis
What is the OTC Analgesics Demand Outlook for the U.S.?
The U.S. over-the-counter (OTC) analgesics market is expected to increase 1.5X by 2031.
Many patients in the United States rely on ineffective analgesics to treat muscle injuries and disorders. Moreover, the rising number of surgeries, combined with the widespread availability of effective pain management medications in the country, is expected to propel the market forward over the forecast period.
In the U.S., factors such as improving economic conditions, rise in prevalence of chronic pain, and growing use of internal OTC analgesics and external OTC analgesics among individuals have a significant impact on the demand for OTC analgesics.
How Lucrative is the Market for OTC Analgesics in China?
Growing usage of OTC analgesics, presence of major pharmaceutical industry players, and improved patient care reforms are factors are expected to boost market growth in China over the forecast period.
Rise in disease burden, rapid increase in research, and large number of key players expanding their business in the country are expected to drive market growth.
Category-wise Insights
Why are Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in Such High Demand?
Demand for NSAIDs is expected to increase by 1.6X over the forecast period. Non-opioid analgesics are nonsteroidal anti-inflammatory drugs (NSAIDs). They are mainly of three types: aspirin, ibuprofen, and naproxen.
NSAIDs work by inhibiting the production of certain chemicals in the body that causes inflammation. NSAIDs are useful in curing pain caused by slow tissue damage, like arthritis pain and are expected to fuel the demand for OTC nonsteroidal anti-inflammatory drugs.
They're frequently used to treat headaches, menstrual cramps, sprains and strains, colds and flu, arthritis, and other mild to moderate pain conditions. They are more effective than acetaminophen and are generally used to treat mild pain symptoms all over the body. Hence the sales of OTC nonsteroidal anti-inflammatory drugs have increased.
All these factors are contributing to the growth of the OTC nonsteroidal anti-inflammatory drugs (NSAIDs) market.
Which OTC Channel Will be Preferred for Sales of OTC Analgesics?
According to OTC channel analysis, pharmacies will continue to be the most popular OTC channel for sales of OTC analgesics over the coming years.
A pharmacy is a one-stop-shop for OTC analgesics that can be used at home. Many people can't afford to go to the doctor on a regular basis and instead rely on OTC products. Hence, individuals are gradually shifting their preference towards pharmacies for purchasing medicines.
Wider availability of OTC analgesics in pharmacies, affordability, and easy accessibility are boosting sales of OTC acetaminophen and OTC salicylates through pharmacies.
Competitive Landscape
With several OTC analgesics product manufacturers, the market is fiercely competitive.
Rising prevalence of pain-related conditions will open up a variety of new business opportunities. To take advantage of the opportunities, OTC analgesics manufacturing companies should concentrate on expanding their consumer base and strengthening their competitive position.
- In May 2020, The European Commission has started the European Research Area (ERA) corona platform that will provide details on COVID-19 innovative solutions. Furthermore, the European Medicine Agency has suggested that mild COVID-19 symptoms be treated with non-steroidal anti-inflammatories (NSAIDs), such as ibuprofen and paracetamol, in the lowest dose form.
OTC Analgesics Industry Report Scope
| Attributes | Details |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | Value in US$ Mn, Volume in Cubic Meters |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East Africa |
| Key Countries Covered | U.S., Canada, Mexico, Brazil, Mexico, Argentina, Germany, Italy, France, U.K, Nordic, Spain, Japan, China, India, Malaysia, Thailand, Australia, GCC Countries, South Africa, Turkey |
| Key Market Segments Covered | Form, Drug Type, OTC Channel, Region |
| Key Companies Profiled | Bayer AG; Boehringer Ingelheim International GmbH; Johnson & Johnson; GlaxoSmithKline PLC; Pfizer Inc.; Reckitt Benckiser Group PLC; Sanofi SA; Sun Pharmaceutical Industries Ltd; Takeda Pharmaceutical Company Limited; AstraZeneca PLC; Merck & Co Inc.; Novartis AG |
| Pricing | Available upon Request |
Key Market Segments in OTC Analgesics Industry Research
-
By Form :
- OTC Analgesic Tablets
- OTC Analgesic Capsules
- OTC Analgesic Liquid
-
By Drug Type :
- OTC Acetaminophen
- OTC Salicylates
- OTC Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
-
By OTC Channel :
- Sales of OTC Analgesics at Pharmacies
- Sales of OTC Analgesics at Drug Stores
- Online Sales of OTC Analgesics
- Modern Trade Sales of OTC Analgesics
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Global Market Analysis and Forecast By OTC Channel
- 3.1. Pharmacy
- 3.2. Drug Store
- 3.3. Modern Trade
- 3.4. Online Store
- 3.5. Other Retail
- 4. Global Market Analysis and Forecast By Product Form
- 4.1. Liquid
- 4.2. Capsule
- 4.3. Tablet
- 5. Global Market Analysis and Forecast By Region
- 5.1. North America
- 5.2. Latin America
- 5.3. Europe
- 5.4. Japan
- 5.5. APEJ
- 5.6. MEA
- 6. North America Market Analysis and Forecast, By Country, 2016 to 2031
- 7. Latin America Market Analysis and Forecast, By Country, 2016 to 2031
- 8. Europe Market Analysis and Forecast, By Country, 2016 to 2031
- 9. Japan Market Analysis and Forecast, By Country, 2016 to 2031
- 10. APEJ Market Analysis and Forecast, By Country, 2016 to 2031
- 11. MEA Market Analysis and Forecast, By Country, 2016 to 2031
- 12. Global Market Company/Manufacturers/Distributors/Suppliers Profile and Revenue Projections
- 12.1. Company Share Analysis
- 12.2. Reckitt Benckiser Group Plc.
- 12.3. Johnson & Johnson Service, Inc.
- 12.4. GlaxoSmithKline Plc.
- 12.5. Novartis AG
- 12.6. AstraZeneca Plc.
- 12.7. Sun Pharmaceutical Industries Ltd.
- 12.8. Pfizer Inc.
- 12.9. Prestige Brands Holdings, Inc.
- 12.10. Procter & Gamble Co.
- 12.11. Merck & Co.
- 12.12. Bristol-Myers Squibb Co.
- 12.13. Allergan
- 12.14. Sanofi-Aventis
- 13. Research Methodology
- 14. Secondary and Primary Sources
- 15. Assumptions and Acronyms
- 16. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 1 Global Market Value (US$ Mn), 2016 to 2020
TABLE 2 Global Market Value (US$ Mn), 2021 to 2031
TABLE 3 Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2031
TABLE 4 Global Pharmacy Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 5 Global Pharmacy Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 6 Global Pharmacy Segment Market Share, By Region 2016 to 2020
TABLE 7 Global Pharmacy Segment Market Share, By Region 2021 to 2031
TABLE 8 Global Pharmacy Segment Y-o-Y, By Region 2015 to 2031
TABLE 9 Global Drug Store Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 10 Global Drug Store Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 11 Global Drug Store Segment Market Share, By Region 2016 to 2020
TABLE 12 Global Drug Store Segment Market Share, By Region 2021 to 2031
TABLE 13 Global Drug Store Segment Y-o-Y, By Region 2015 to 2031
TABLE 14 Global Modern Trade Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 15 Global Modern Trade Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 16 Global Modern Trade Segment Market Share, By Region 2016 to 2020
TABLE 17 Global Modern Trade Segment Market Share, By Region 2021 to 2031
TABLE 18 Global Modern Trade Segment Y-o-Y, By Region 2015 to 2031
TABLE 19 Global Online Store Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 20 Global Online Store Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 21 Global Online Store Segment Market Share, By Region 2016 to 2020
TABLE 22 Global Online Store Segment Market Share, By Region 2021 to 2031
TABLE 23 Global Online Store Segment Y-o-Y, By Region 2015 to 2031
TABLE 24 Global Other Retail Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 25 Global Other Retail Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 26 Global Other Retail Segment Market Share, By Region 2016 to 2020
TABLE 27 Global Other Retail Segment Market Share, By Region 2021 to 2031
TABLE 28 Global Other Retail Segment Y-o-Y, By Region 2015 to 2031
TABLE 29 Global Liquid Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 30 Global Liquid Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 31 Global Liquid Segment Market Share, By Region 2016 to 2020
TABLE 32 Global Liquid Segment Market Share, By Region 2021 to 2031
TABLE 33 Global Liquid Segment Y-o-Y, By Region 2015 to 2031
TABLE 34 Global Capsule Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 35 Global Capsule Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 36 Global Capsule Segment Market Share, By Region 2016 to 2020
TABLE 37 Global Capsule Segment Market Share, By Region 2021 to 2031
TABLE 38 Global Capsule Segment Y-o-Y, By Region 2015 to 2031
TABLE 39 Global Tablet Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 40 Global Tablet Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 41 Global Tablet Segment Market Share, By Region 2016 to 2020
TABLE 42 Global Tablet Segment Market Share, By Region 2021 to 2031
TABLE 43 Global Tablet Segment Y-o-Y, By Region 2015 to 2031
TABLE 44 North America Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 45 North America Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 46 North America Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 47 North America Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 48 Latin America Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 49 Latin America Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 50 Latin America Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 51 Latin America Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 52 Europe Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 53 Europe Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 54 Europe Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 55 Europe Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 56 Japan Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 57 Japan Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 58 Japan Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 59 Japan Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 60 APEJ Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 61 APEJ Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 62 APEJ Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 63 APEJ Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 64 MEA Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 65 MEA Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 66 MEA Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 67 MEA Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 68 US Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 69 US Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 70 US Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 71 US Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 72 Canada Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 73 Canada Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 74 Canada Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 75 Canada Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 76 Brazil Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 77 Brazil Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 78 Brazil Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 79 Brazil Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 80 Mexico Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 81 Mexico Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 82 Mexico Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 83 Mexico Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 84 Argentina Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 85 Argentina Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 86 Argentina Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 87 Argentina Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 88 Germany Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 89 Germany Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 90 Germany Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 91 Germany Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 92 UK Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 93 UK Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 94 UK Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 95 UK Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 96 France Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 97 France Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 98 France Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 99 France Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 100 Spain Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 101 Spain Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 102 Spain Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 103 Spain Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 104 Italy Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 105 Italy Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 106 Italy Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 107 Italy Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 108 Nordic Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 109 Nordic Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 110 Nordic Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 111 Nordic Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 112 Japan Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 113 Japan Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 114 Japan Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 115 Japan Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 116 China Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 117 China Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 118 China Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 119 China Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 120 India Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 121 India Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 122 India Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 123 India Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 124 Malaysia Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 125 Malaysia Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 126 Malaysia Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 127 Malaysia Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 128 Thailand Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 129 Thailand Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 130 Thailand Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 131 Thailand Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 132 Singapore Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 133 Singapore Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 134 Singapore Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 135 Singapore Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 136 Australia Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 137 Australia Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 138 Australia Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 139 Australia Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 140 GCC Countries Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 141 GCC Countries Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 142 GCC Countries Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 143 GCC Countries Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 144 South Africa Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 145 South Africa Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 146 South Africa Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 147 South Africa Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 148 Nigeria Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 149 Nigeria Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 150 Nigeria Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 151 Nigeria Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 152 Israel Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 153 Israel Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 154 Israel Market Value (US$ Mn), By Product Form 2016 to 2020
TABLE 155 Israel Market Value (US$ Mn), By Product Form 2021 to 2031
TABLE 156 Reckitt Benckiser Group Plc. Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 157 Reckitt Benckiser Group Plc. Value (US$ Mn), By Product Form 2021 to 2031
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 1 Global Market Value (US$ Mn), 2016 to 2020
FIG. 2 Global Market Value (US$ Mn) Forecast, 2021 to 2031
FIG. 3 Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2031
FIG. 4 Global Pharmacy Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 5 Global Pharmacy Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 6 Global Pharmacy Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 7 Global Drug Store Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 8 Global Drug Store Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 9 Global Drug Store Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 10 Global Modern Trade Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 11 Global Modern Trade Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 12 Global Modern Trade Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 13 Global Online Store Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 14 Global Online Store Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 15 Global Online Store Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 16 Global Other Retail Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 17 Global Other Retail Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 18 Global Other Retail Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 19 Global Liquid Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 20 Global Liquid Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 21 Global Liquid Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 22 Global Capsule Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 23 Global Capsule Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 24 Global Capsule Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 25 Global Tablet Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 26 Global Tablet Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 27 Global Tablet Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 28 North America Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 29 North America Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 30 North America Market Value (US$ Mn), By Product Form 2016 to 2020
FIG. 31 North America Market Value (US$ Mn), By Product Form 2021 to 2031
FIG. 32 Latin America Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 33 Latin America Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 34 Latin America Market Value (US$ Mn), By Product Form 2016 to 2020
FIG. 35 Latin America Market Value (US$ Mn), By Product Form 2021 to 2031
FIG. 36 Europe Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 37 Europe Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 38 Europe Market Value (US$ Mn), By Product Form 2016 to 2020
FIG. 39 Europe Market Value (US$ Mn), By Product Form 2021 to 2031
FIG. 40 Japan Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 41 Japan Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 42 Japan Market Value (US$ Mn), By Product Form 2016 to 2020
FIG. 43 Japan Market Value (US$ Mn), By Product Form 2021 to 2031
FIG. 44 APEJ Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 45 APEJ Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 46 APEJ Market Value (US$ Mn), By Product Form 2016 to 2020
FIG. 47 APEJ Market Value (US$ Mn), By Product Form 2021 to 2031
FIG. 48 MEA Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 49 MEA Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 50 MEA Market Value (US$ Mn), By Product Form 2016 to 2020
FIG. 51 MEA Market Value (US$ Mn), By Product Form 2021 to 2031
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current market worth for OTC analgesics?
The global over-the-counter (OTC) analgesics market is currently worth more than US$ 25 Bn.
What was the last 5 year market CAGR for OTC analgesics?
From 2016 to 2020, market CAGR was around 2% for OTC analgesics.
What are the key trends likely to influence sales of OTC analgesics?
Rising geriatric population and cost efficiency of OTC drugs are key trends that are driving sales of OTC analgesics.
What is the market outlook for OTC analgesics in Canada?
Sales of OTC analgesics in Canada are forecasted to top US$ 7 Bn by 2031.
Who are the prominent players operating in this space?
Key OTC analgesics suppliers are Bayer AG, Boehringer Ingelheim International GmbH, Johnson & Johnson, GlaxoSmithKline PLC, and Pfizer Inc.
Which region is more attractive for vendors of OTC analgesics?
With 40% share, North America will largely contribute to the growth of OTC analgesics revenue.
How lucrative is the opportunity for expansion in Germany?
OTC analgesic sales in Germany are expected to rise at a CAGR of 3% over the forecast period of 2021 to 2031.
Which segment has the largest share in the OTC analgesics space?
Nonsteroidal anti-inflammatory drugs (NSAIDs) account for a share of 50% in the market.
Which are the top 5 countries driving demand for OTC analgesics?
The U.S., China, U.K, Germany, and France are expected to drive most of the demand for OTC analgesics.
What is the predicted expansion rate for the market over the next ten years?
The global market is expected to expand at a CAGR of 5% over the forecast period of 2021 to 2031.
Over the Counter (OTC) Analgesics Market